Form 4: Delcath Systems Director Steven Salamon Acquires Additional Shares
SEC Form 4
Director Steven Salamon purchased 26,882 shares of Delcath Systems at $3.72 per share on March 19, 2024, increasing his total holdings to 1,121,025 shares.
Summary
- On March 19, 2024, Steven Salamon, a director of Delcath Systems, Inc., acquired 26,882 common shares of the company.
- The shares were purchased at a price of $3.72 per share.
- Following the transaction, Salamon's total beneficial ownership of Delcath Systems common shares increased to 1,121,025.
- Salamon directly owns 1,121,025 shares.
- 1,038,828 shares are indirectly owned by the Reporting Person as Officer(s) of Rosalind Advisors, Inc., the advisor to Rosalind Opportunities Fund I L.P. and Rosalind Master Fund L.P.
Sentiment
Score: 6
Explanation: The sentiment is neutral to slightly positive. A director purchasing shares suggests confidence, but it's a relatively small transaction.
Positives
- A director's purchase of shares can be seen as a positive signal, indicating confidence in the company's future prospects.
Industry Context
Form 4 filings are a routine part of insider trading regulations, providing transparency into the transactions of company insiders. This information is closely watched by investors seeking insights into management's perspective on the company's value and future.
Stakeholder Impact
- The purchase could have a slightly positive impact on shareholder sentiment.
Key Dates
| Date | Description |
|---|---|
| 03/19/2024 | Date of transaction: Steven Salamon purchased 26,882 shares of Delcath Systems. |
| 03/20/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.